These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5917090)

  • 1. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine).
    Main AR; Hastings FL
    Science; 1966 Oct; 154(3747):400-2. PubMed ID: 5917090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase inhibition by eserine: rate constants of reaction. Part II.
    Brufani M; Lippa S; Marta M; Oradei A; Pomponi M
    Ital J Biochem; 1985; 34(5):328-40. PubMed ID: 4077467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the in vitro inhibition of acetylcholinesterase by the carbamate inhibitor eserine sulphate in eserine resistant strains of Drosophila melanogaster.
    Burnell AM; Wilkins NP
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(1):215-20. PubMed ID: 2904861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
    Dawson RM
    Neurochem Int; 1994 Feb; 24(2):173-82. PubMed ID: 8161944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new simple method for determining the kinetic constants of inhibited acetylcholinesterase.
    Brufani M; Lippa S; Littarru GP; Oradei A; Pomponi M
    Ital J Biochem; 1984; 33(5):325-32. PubMed ID: 6511307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and dilution effects on the inhibition of acetylcholinesterase by carbamates.
    Winteringham FP; Fowler KS
    Biochem J; 1966 Oct; 101(1):127-34. PubMed ID: 5971773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
    Stojan J; Zorko M
    Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
    Rush RS; Doctor BP; Wolfe AD
    Biochem Pharmacol; 1986 Dec; 35(23):4167-70. PubMed ID: 3098245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of eserine action on the hydrolysis of butyrylthiocholine by butyrylcholinesterase.
    Stojan J; Pavlic MR
    J Enzyme Inhib; 1997 Jan; 11(3):199-208. PubMed ID: 9204388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompetitive inhibition of acetylcholinesterase by eserine.
    Stein HH; Lewis GJ
    Biochem Pharmacol; 1969 Jul; 18(7):1679-84. PubMed ID: 5806108
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient kinetic approach to the study of acetylcholinesterase reversible inhibition by eseroline.
    Golicnik M; Stojan J
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):279-85. PubMed ID: 12683744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds.
    Green AL
    Biochem Pharmacol; 1983 Jun; 32(11):1717-22. PubMed ID: 6870912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
    Marta M; Gatta F; Pomponi M
    Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
    Dawson RM
    Neurochem Int; 1995 Jun; 26(6):643-54. PubMed ID: 7670367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase. II. A study by nuclear magnetic resonance of the acceleration of acetylcholinesterase by atropine and inhibition by eserine.
    Kato G
    Mol Pharmacol; 1972 Sep; 8(5):582-8. PubMed ID: 5083615
    [No Abstract]   [Full Text] [Related]  

  • 16. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.
    Perola E; Cellai L; Lamba D; Filocamo L; Brufani M
    Biochim Biophys Acta; 1997 Nov; 1343(1):41-50. PubMed ID: 9428657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
    Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
    J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
    Debord J; Laubarie C; Dantoine T
    Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.